13 March 2024 – Bengaluru-based Cureskin, an AI-powered dermatology platform offering clinically validated solutions for skin and hair health, has secured $20 million in its Series B funding round. Founded with the mission to address the scarcity of qualified dermatologists in India, Cureskin aims to democratize access to quality dermatological care.
Cureskin Background:
Led by HealthQuad, a prominent digital health-focused venture capital fund in India, the Series B round saw participation from existing investors including JSW Ventures, Khosla Ventures, and Sharrp Ventures. With this latest funding, Cureskin’s total investment stands at $26 million, reinforcing its commitment to revolutionizing dermatological care in India.
India faces a significant deficit in access to dermatological services, particularly in remote and underserved areas. Cureskin’s AI-driven platform fills this void by leveraging technology to extend the reach of dermatological expertise. By treating over 1.5 million customers through its mobile app, Cureskin has made substantial strides in addressing various skin and hair conditions, with a focus on Tier 2 and 3 cities.
Conclusion:
The successful Series B funding not only validates Cureskin’s innovative approach but also positions the company for accelerated growth and impact. With plans to further enhance its AI capabilities and expand its solution offerings, Cureskin is poised to play a pivotal role in advancing skin and hair health across India. As the company continues its mission to empower individuals with accessible and effective dermatological care, it remains at the forefront of leveraging technology for positive societal change.
